ANTIBIOTIC SUSCEPTIBILITY OF CLINICAL ISOLATES OF PSEUDOMONAS AERUGINOSA
DOI:
https://doi.org/10.11603/1681-2727.2016.3.6895Keywords:
Pseudomonas aeruginosa, pyo-inflammatory processes, sensitivity to antimicrobial drugs.Abstract
The results of research of sensitivity to antimicrobial chemotherapy drugs of Pseudomonas aeruginosa isolated from patients with pyo-inflammatory processes of different localization of the urinary tract, ENT-organs, wound contents with mucoviscidosis. For the empirical treatment were revealed the drugs of choice for patients to establish the sensitivity of antimicrobial agents. It has been shown that for an effective treatment could be recommended a limited set of antibiotics, especially, for infections of the urinary tract – piperacillin/tazobactam, cefepim, meropenem, amikacin; for the ENT-organs – piperacillin/tazobactam, cefoperazone, ciprofloxacin, amikacin; piperacillin/tazobactam, ciprofloxacin- when festering; piperacillin/tazobactam, meropenem, cefoperazone – for patients with mucoviscidosis of wound contents.References
Yegorova O.N. Epidemiologiya i profilaktika sinegnoynoy infektsii / O.N. Yegorova, Ye.B. Brusina, Ye.V. Grigor'yev // Federal'nyye klinicheskiye rekomendatsii. – M., 2014. – 82 s.
A Systems Biology Approach to Drug Targets in Pseudomonas aeruginosa Biofilm / G. Sigurdsson, R.M. Fleming, A. Heinken [et al.] // PLoS One. – 2012. – Vol. 7, N 4. – P. 337-343.
DiMondi V.P. Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection / V.P. DiMondi, M.L. Townsend, R.H. Drew // Int. J. Clin. Pharm. – Epub 2015 Jan 31. – R. 348-354.
El-Azizi M. Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro / M. El-Azizi // Int. J. Microbiol. – Epub 2016 Apr 18.
Rudnov V.A. Antibiotikoterapiya gospital'nykh infektsiy, vyzvannykh P. aeruginosa / V.A. Rudnov // Russ. med. zhurn. – 2005. – T. 13, № 7. – C. 38-41.
Carmeli Y. The effects of 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study / Y. Carmeli, L. Shiri Rlarfeld // Dmid. Journal. – 2011. – Vol. 70, N 3. – P. 27-29.
Shelyakova O.A. Problema rezistentnosti PSEUDOMONAS AERUGINOSA k antibiotikam / O.A. Shelyakova // Sovremennaya meditsina: aktual'nyye voprosy: sb. st. po mater. XVII mezhdunar. nauch.-prakt. konf. – Novosibirsk: SibAK, 2013. – C. 43-47.
Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates / H. Er, M. Altındiş, G. Aşık, C. Demir // Mikrobiyol. Bul. – 2015. – Vol.49, N 2. – P. 156-165.
Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains / Z. Aktaş, D. Satana, C. Kayacan [et al.] // Mikrobiyol. Bul. – 2012. – Vol. 46, N 3. – R. 386-397.
Solovey N.V. Problema mul'tirezistentnosti sinegnoynoy palochki v mnogoprofil'nom statsionare / N.V. Solovey, I.A. Karpov // KMAKH. – 2012. – T. 14, № 2. – S. 49.
Klinicheskaya laboratornaya analitika / Pod red. V.V. Men'shikova. – M.: Agat-Med, 2003. – T. IV. – 815 s.
Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran / H.R. Goli, M.R. Nahaei, M. Ahangarzadeh Rezaee [et al.] // Iran J. Microbiol. – 2016. – Vol. 8, N 1. – R. 62-69.
Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected Rseudomonas aeruginosa / J. Cotrina-Luque, M.V. Gil-Navarro, H. Acosta-García [et al.] // Int. J. Clin. Pharm. – 2015. – P. 256-260.
Microbiological characteristics of sepsis in a University hospital / A.V. Vendemiato, A Nowakonski, F.A. Marson, C.E. Levy // BMC Infect. Dis. – 2015. – P. 66-69.
Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome / R.C. Dantas, M.L. Ferreira, P.P. Gontijo-Filho, R.M. Ribas // J. Med. Microbiol. – 2014. – Vol. 63, N 12. – R. 1679-1687.
Yefimenko N.A. Infektsii v khirurgii / N.A. Yefimenko, I.A. Guchev, S.V. Sidorenko. – Smolensk, 2004. – 296 s.
Downloads
Published
How to Cite
Issue
Section
License
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
